Anti-Human IFN alpha Recombinant Antibody (Rontalizumab)

Recombinant monoclonal antibody to IFN alpha. Rontalizumab is a humanized monoclonal antibody. for treatment of systemic lupus erythematosus.

Specifications

• Immunogen

• The details of the immunogen for this antibody are not available.

• Host Species

• Mouse

• Derivation

• Humanized (from mouse)

• Type

• IgG1 - kappa

• Specificity

• Tested positive against native human antigen.

• Species Reactivity

• Human

• Applications

• WB

• CAS

• 948570-30-7

• Generic Name

• Rontalizumab

• UNII

• LDO2FIQ61I

• MW

• 145.9 kDa

• Related Disease

• Systemic lupus erythematosus (SLE)